Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.58
+0.04 (0.72%)
At close: Oct 17, 2025, 4:00 PM EDT
5.52
-0.06 (-1.08%)
After-hours: Oct 17, 2025, 7:40 PM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $352.87 million as of October 17, 2025. Its market cap has increased by 412.93% in one year.
Market Cap
352.87M
Enterprise Value
330.52M
1-Year Change
412.93%
Ranking
Category
Stock Price
$5.58
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $352.87M, a decrease of -3.55%. That is a compound annual growth rate of -0.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 350.34M | 412.86% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |